Plant compound found to have therapeutic effect on complications from snakebites

October 11, 2018, Public Library of Science
Plant compound found to have therapeutic effect on complications from snakebites
"Jararaca (Bothrops jararaca). This photo was taken circa 2002 in Itatiaia, Rio de Janeiro, Brazil." Credit: Felipesussekind, Flickr, 2002, https://www.flickr.com/photos/felipesussekind/5992689190/

Rutin, a flavonoid, may complement antivenom as an effective co-treatment for envenoming from Bothrops jaraca.

Researchers have found that rutin, an inexpensive, plant-based compound may protect envenomed mice from bleeding and inflammation problems, according to a study published in PLOS Neglected Tropical Diseases by Ana Teresa Azevedo Sachetto of Institute Butantan, São Paulo, Brazil.

Anti-venom can effectively treat the major manifestations of snakebites, however, there are no known therapies effective for common secondary complications. Venom toxins from Bothrops jaraca (lance-headed vipers) may trigger bleeding, disrupt oxidation reduction in cells, and inhibit the body's ability to stop bleeding. Researchers injected both venom and rutin into a group of mice, then analyzed blood and tissue samples to understand what effect(s) if any, the rutin had on pathophysiological events triggered by Bothrops jararaca venom.

The mechanisms of clinical complications in patients bitten by B. jaraca snakes are not well understood and antivenom therapy is limited in its ability to treat the full array of complications that may occur following a . Future studies will be necessary to understand rutin activity once venom has initiated pathophysiological events, as well the therapeutic effects of rutin delivered with antivenom. According to the authors, the research "indicates that rutin has a great potential as an ancillary drug in concert with antivenom to treat snakebites, particularly in countries where availability is scarce."

Explore further: Nanoparticles to treat snakebites

More information: Sachetto ATA, Rosa JG, Santoro ML (2018) Rutin (quercetin-3-rutinoside) modulates the hemostatic disturbances and redox imbalance induced by Bothrops jararacasnake venom in mice. PLOS Neglected Tropical Diseases 12(10): e0006774. doi.org/10.1371/journal.pntd.0006774

Related Stories

Nanoparticles to treat snakebites

October 4, 2018
Venomous snakebites affect 2.5 million people, and annually cause more than 100,000 deaths and leave 400,000 individuals with permanent physical and psychological trauma each year. Researchers reporting in PLOS Neglected ...

High-tech breakthrough in snakebite antivenom

October 2, 2018
An experimental antivenom has been developed against dendrotoxins from the world's most feared venomous snake, the black mamba, which can be found in Africa. The experiments were carried out in collaboration between DTU and ...

A synthetic biology approach for a new antidote to coral snake venom

March 3, 2016
Coral snake venom carries significant neurotoxicity and human injuries can be severe or even lethal. Despite this, antivenom treatments are scarce due to challenges collecting adequate amounts of venom needed to produce anti-elapidic ...

Why tiger snakes are on a winner

August 22, 2017
Australian tiger snakes have "hit the jackpot" because prey cannot evolve resistance to their venom.

How just drops of viper venom pack a deadly punch

June 1, 2018
A bite from a lancehead snake can be fatal. Species in the family, found throughout Central and South America, have venom that can disrupt blood clotting and cause hemorrhage, strokes and kidney failure.

Researchers take a novel approach to snakebite treatment

April 19, 2018
Researchers at LSTM's Alistair Reid Venom Research Unit are looking at treatment for snakebite in a completely different way and have shown that it is possible to treat the bite from one snake with antivenom produced from ...

Recommended for you

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.